Sentence examples for biotechnology issues from inspiring English sources

Biotechnology issues, hit hard last week, were beaten down again yesterday.

Biotechnology issues, which have been giving back some of their gains lately, were lower for a fourth day.

The Market Came to Them An 80percentt stake in technology stocks, with a sprinkling of biotechnology issues, pushed the $1.22 billion Kopp Emerging Growth fund into the No. 3 place for the quarter, with a return of 42.3percentt.

"People may look at this differently than some of the transspecies work but some of the risks they worry about would still be there," said Dr. Margaret Mellon, who tracks biotechnology issues at the Union of Concerned Scientists in Washington.

And the performance of those stocks has not matched that of biotechnology issues, which have nothing to do with the Internet but which have suddenly come alive in their strongest performance since 1992, when biotechnology stocks dominated market speculation.

The boom in US biotechnology issues that began a year ago multiplied IBT's asset value as the imminence of the completion of the human genome project spurred on some remarkable gains.

"Can you imagine?" Life-extending technology is a serious enough prospect to have merited its own chapter in "Beyond Therapy," a report on biotechnology issued last fall by the President's Council on Bioethics.

The union, an independent organization that has opposed the Bush administration on environmental policies and the Clinton administration on biotechnology, issued a report last Wednesday accusing the administration of distorting science to serve its political goals.

President Bush has appointed a committee, led by Dr. Leon R. Kass, to advise him on biotechnology and issues related to the beginning of human life.

Chapotin is in her second year at the U.S. Agency for International Development (USAID), where she enjoys the "big picture" view that working on biotechnology safety issues provides--a view she never had in the lab.

The panel, known as the Biotechnology Consultative Forum, was established after the last United States-European Union summit meeting in May to discuss biotechnology-related issues that have led to trade tensions between Washington and Brussels.